Shunji Tomatsu

Shunji Tomatsu

Auto-generated profile, based on publicly available information

Shunji Tomatsu

Department of Pediatrics, Gifu University School of Medicine, Gifu, Japan

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2008
Verified
Journal Article
Closed access
MGMónica A Gutiérrez
Mónica A Gutiérrez
FGFelipe García-Vallejo
Felipe García-Vallejo
STShunji Tomatsu
Shunji Tomatsu
FCFlavio Cerón
Flavio Cerón
Carlos Javier Alméciga-DíazCarlos Javier Alméciga-Díaz
Carlos Javier Alméciga-Díaz
LBLuis A Barrera
Luis A Barrera

28 February 2009 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
Carlos Javier Alméciga-DíazCarlos Javier Alméciga-Díaz
Carlos Javier Alméciga-Díaz
AMAdriana Montaqo
Adriana Montaqo
LBLuis Barera
Luis Barera
STShunji Tomatsu
Shunji Tomatsu

1 February 2015 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
Francyne KubaskiFrancyne Kubaski
Francyne Kubaski
TSTsutomu Shimada
Tsutomu Shimada
STShunji Tomatsu
Shunji Tomatsu
RMRobert W. Mason
Robert W. Mason
EYEriko Yasuda
Eriko Yasuda
TOTadao Orii
Tadao Orii

1 January 1997 in Human Mutation
Verified
Journal Article
Closed access
PDF file
STShunji Tomatsu
Shunji Tomatsu
SFSeiji Fukuda
Seiji Fukuda
ACAlan Cooper
Alan Cooper
JWJames E. Wraith
James E. Wraith
PFPatrick Ferreira
Patrick Ferreira
TOTadao Orii
Tadao Orii
Mucopolysaccharidosis IVA (MPS IVA) is an autosomal recessive disorder caused by a deficiency of the lysosomal N‐acetylgalactosamine‐6‐sulfate sulfatase. Here, we report our analysis of data on 21 patients of diverse ethnic and geographic origins studied by SSCP and sequencing analysis. Sixteen mutations were detected, including 14 new mutations (11 missense, one premature termination, one splice site alteration, and one cryptic site alteration). The donor splice site mutation (IVS4 + 1G→A) predicts that normal splicing will be abolished and that translation would lead to an immediate premature termination (W141X). Another novel nucleotide change outside the coding sequence is an intronic alteration (IVS9‐42C→T:ggtcggtgcggttggtgc) creating a potential cryptic donor site. The nucleotide sequence surrounding this alteration is highly suggestive of a consensus donor splice site. All 12 missense and nonsense mutations were shown by transient expression to abolish or greatly reduce GALNS activity, thereby providing an explanation as to why they produce MPS IVA. All mutations were readily confirmed by restriction enzyme or by allelic specific oligonucleotide analysis (ASO). These findings, coupled with previously reported mutations, bring the total of different mutations to 41 among independent families with MPS IVA, illustrating the extensive allelic heterogeneity among mutations producing MPS IVA. Hum Mutat 10:368–375, 1997.

1 February 2013 in Molecular Genetics and Metabolism
Verified
Journal Article
Closed access
ASAngela Sosa-Molano
Angela Sosa-Molano
BKBarbara Kariuki
Barbara Kariuki
AKAlan Knutsen
Alan Knutsen
CBClifford Bellone
Clifford Bellone
STShunji Tomatsu
Shunji Tomatsu
AMAdriana Montaño
Adriana Montaño

1 January 1997 in Human Mutation
Verified
Journal Article
Closed access
PDF file
SBSusanna Bunge
Susanna Bunge
WKWim J. Kleijer
Wim J. Kleijer
ATAnna Tylki-Szymanska
Anna Tylki-Szymanska
CSCordula Steglich
Cordula Steglich
MBMichael Beck
Michael Beck
AGAndreas Gal
Andreas Gal
Mutation analysis of the N‐acetylgalactosamine‐6‐sulfate sulfatase gene was performed in a group of 35 patients with mucopolysaccharidosis type IVA from 33 families, mainly of European origin. By nonradioactive SSCP screening, 35 different gene mutations were identified, 31 of them novel. Together they account for 88.6% of the disease alleles of the patients investigated. The vast majority of the gene alterations proved to be point mutations, 23 missense, 2 nonsense, and 3 affecting splicing. Six small deletions (1–27 bp) and one insertion were also characterized. In a Polish family, two mildly affected siblings were compound heterozygotes for R94G and R259Q. Their mother was homozygous for the latter point mutation, leading to enzyme deficiency and a borderline disease phenotype. Hum Mutat 10:223–232, 1997.